ASLAN Pharmaceuticals Limited (NASDAQ: ASLN)
$1.41
-1.1400 ( -44.70% ) 1.1M
ASLAN Pharmaceuticals Ltd is a clinical-stage immunology-focused biopharmaceutical company developing innovative treatments to transform the lives of patients. The company is evaluating ASLAN004, a potential first-in-class antibody targeting the IL-13 receptor, in atopic dermatitis, and ASLAN003, a potent oral inhibitor of DHODH, which is being developed for autoimmune disease. The Company's major business is research and development and operates only in one single segment.
Market Data
Open
$1.41
Previous close
$2.55
Volume
1.1M
Market cap
$3.90M
Day range
$1.18 - $2.55
52 week range
$1.18 - $25.44
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
6-k | Quarterly Reports | 3 | Jul 15, 2024 |
6-k | Quarterly Reports | 3 | Jun 14, 2024 |
6-k | Quarterly Reports | 3 | May 31, 2024 |
6-k | Quarterly Reports | 3 | May 09, 2024 |
6-k | Quarterly Reports | 3 | May 07, 2024 |
6-k | Quarterly Reports | 3 | Apr 22, 2024 |
6-k | Quarterly Reports | 3 | Apr 19, 2024 |
6-k | Quarterly Reports | 3 | Apr 12, 2024 |
6-k | Quarterly Reports | 3 | Apr 12, 2024 |
20-f | Annual reports | 139 | Apr 12, 2024 |